- Report
- November 2024
- 73 Pages
Global
From €3500EUR$4,093USD£3,079GBP
- Report
- May 2025
- 50 Pages
Global
From €2428EUR$2,650USD£2,063GBP
- Report
- May 2025
- 50 Pages
Global
From €2428EUR$2,650USD£2,063GBP
Alverine is a drug used in the treatment of gastrointestinal disorders. It is a type of antispasmodic, which works by relaxing the muscles of the digestive tract. This helps to reduce pain and discomfort associated with gastrointestinal disorders such as irritable bowel syndrome (IBS). Alverine is available in both oral and injectable forms, and is often used in combination with other medications.
The alverine market is a growing segment of the gastrointestinal drugs market. It is used to treat a variety of gastrointestinal disorders, and is increasingly being prescribed as a first-line treatment for IBS. Alverine is also used to treat other conditions such as diverticulitis and colitis.
The alverine market is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more